Novel Cruzain Inhibitors for the Treatment of Chagas’ Disease

The protozoan parasite Trypanosoma cruzi, the etiological agent of Chagas’ disease, affects millions of individuals and continues to be an important global health concern. The poor efficacy and unfavorable side effects of current treatments necessitate novel therapeutics. Cruzain, the major cysteine...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Kathleen E, Keränen, Henrik, Durrant, Jacob D, Ratnam, Joseline, Doak, Allison, Arkin, Michelle R, McCammon, J Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503458/
https://www.ncbi.nlm.nih.gov/pubmed/22613098
http://dx.doi.org/10.1111/j.1747-0285.2012.01416.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503458/
https://www.ncbi.nlm.nih.gov/pubmed/22613098
http://dx.doi.org/10.1111/j.1747-0285.2012.01416.x

Ejemplares similares